Incepta Pharma LLP
About Incepta Pharma LLP
Data last updated:
Incepta Pharma LLP is a limited liability partnership (LLP) based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 July 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Nagpur, under LLPIN AAK-1066. Its GSTIN is 27AAGFI5719Q1ZP (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Samir Deodatta Sawwalakhe and Vinod Madanlal Chandak.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Flat No. 604 Jayanti Mansion 3 Pn2 Manish Nagar Manish Nagar Somalwada, Nagpur, Maharashtra, India – 440015.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No. 604 Jayanti Mansion 3 Pn2 Manish Nagar Manish Nagar Somalwada, Nagpur, Maharashtra, India – 440015
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Incepta Pharma LLP
Incepta Pharma has 3 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Deodatta Sawwalakhe | Designated Partner | 24 Jul 2017 | 9 Years 2 Months | Current |
| Vinod Madanlal Chandak Also directs: PSV Pharmaceuticals LLP, Palmaris Lifesciences Private Limited | Designated Partner | 20 Aug 2024 | 2 Years 1 Months | Current |
| Pradeep Joseph Subramani | Designated Partner | 24 Jul 2017 | 9 Years 2 Months | Current |
Financials of Incepta Pharma LLP FY 2025 filings available
Financial Statement Summary of Incepta Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Incepta Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Incepta Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Incepta Pharma LLP
Incepta Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Incepta Pharma LLP
Employment history and EPFO contributions of people linked to Incepta Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Incepta Pharma LLP
Incepta Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGFI5719Q1ZP | Maharashtra | Active | 28 Mar 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Incepta Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Incepta Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Incepta Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Incepta Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Incepta Pharma LLP
Frequently Asked Questions about Incepta Pharma LLP
Incepta Pharma is an active limited liability partnership based in Nagpur, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 24 July 2017 (9+ years old) and is registered under LLPIN AAK-1066.
Incepta Pharma has 3 current designated partners:
- Samir Deodatta Sawwalakhe - Designated Partner
- Vinod Madanlal Chandak - Designated Partner
- Pradeep Joseph Subramani - Designated Partner
The GSTIN of Incepta Pharma is 27AAGFI5719Q1ZP, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Incepta Pharma is AAK-1066. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Incepta Pharma was incorporated on 24 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Nagpur.
The registered office of Incepta Pharma is at Flat No. 604 Jayanti Mansion 3 Pn2 Manish Nagar Manish Nagar Somalwada, Nagpur, Maharashtra, India – 440015.
The total obligation of contribution is ₹1 Lakh.
Incepta Pharma operates in the pharma industry, in the drug formulation and development segment.
Incepta Pharma can be reached at its registered office: Flat No. 604 Jayanti Mansion 3 Pn2 Manish Nagar Manish Nagar Somalwada, Nagpur, Maharashtra, India – 440015.